Loading…
The role of serum podocalyxin levels in recurrent pregnancy loss
To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction. In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortio...
Saved in:
Published in: | European journal of obstetrics & gynecology and reproductive biology 2021-05, Vol.260, p.114-117 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3 |
container_end_page | 117 |
container_issue | |
container_start_page | 114 |
container_title | European journal of obstetrics & gynecology and reproductive biology |
container_volume | 260 |
creator | Yorgancı, Ayçağ Halici Ozturk, Filiz Hancerliogullari, Necati Çandar, Tuba Caglar, Ali Turhan Ozgu-Erdinc, A. Seval |
description | To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction.
In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit.
Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively).
Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses. |
doi_str_mv | 10.1016/j.ejogrb.2021.03.021 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2506287679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030121152100141X</els_id><sourcerecordid>2506287679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwBwh5ySbBj8RJNghU8ZIqsSlrK3YmJZETB7up6N_jKoUl3lwvzp0ZHYSuKYkpoeKujaG1G6diRhiNCY9DnKA5zTMWZSJNTtGccEIjRmk6QxfetyQ8zotzNOP8QGTFHD2sPwE7awDbGntwY4cHW1ldmv1302MDOzAeh58DPToH_RYPDjZ92es9Ntb7S3RWl8bD1TEX6OP5ab18jVbvL2_Lx1WkOaXbSGlIFdVpzuoUFC9UIkqmWZWniRK1yMpK06TOC6EUS7MkJYLoWiWMEiaKMtd8gW6nuYOzXyP4rewar8GYsgc7eslCheWZyIqAJhOqXTjQQS0H13Sl20tK5MGdbOXkTh7cScJliFC7OW4YVQfVX-lXVgDuJyAogV0DTnrdQK-haoKdraxs8_-GH_70gZM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506287679</pqid></control><display><type>article</type><title>The role of serum podocalyxin levels in recurrent pregnancy loss</title><source>ScienceDirect Journals</source><creator>Yorgancı, Ayçağ ; Halici Ozturk, Filiz ; Hancerliogullari, Necati ; Çandar, Tuba ; Caglar, Ali Turhan ; Ozgu-Erdinc, A. Seval</creator><creatorcontrib>Yorgancı, Ayçağ ; Halici Ozturk, Filiz ; Hancerliogullari, Necati ; Çandar, Tuba ; Caglar, Ali Turhan ; Ozgu-Erdinc, A. Seval</creatorcontrib><description>To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction.
In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit.
Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively).
Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2021.03.021</identifier><identifier>PMID: 33765479</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Abortion, Habitual ; Abortion, Induced ; Case-Control Studies ; Endothelial dysfunction ; Female ; Humans ; Miscarriage ; Podocalyxin ; Pregnancy ; Recurrent pregnancy loss ; Sialoglycoproteins</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 2021-05, Vol.260, p.114-117</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33765479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yorgancı, Ayçağ</creatorcontrib><creatorcontrib>Halici Ozturk, Filiz</creatorcontrib><creatorcontrib>Hancerliogullari, Necati</creatorcontrib><creatorcontrib>Çandar, Tuba</creatorcontrib><creatorcontrib>Caglar, Ali Turhan</creatorcontrib><creatorcontrib>Ozgu-Erdinc, A. Seval</creatorcontrib><title>The role of serum podocalyxin levels in recurrent pregnancy loss</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction.
In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit.
Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively).
Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses.</description><subject>Abortion, Habitual</subject><subject>Abortion, Induced</subject><subject>Case-Control Studies</subject><subject>Endothelial dysfunction</subject><subject>Female</subject><subject>Humans</subject><subject>Miscarriage</subject><subject>Podocalyxin</subject><subject>Pregnancy</subject><subject>Recurrent pregnancy loss</subject><subject>Sialoglycoproteins</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EoqXwBwh5ySbBj8RJNghU8ZIqsSlrK3YmJZETB7up6N_jKoUl3lwvzp0ZHYSuKYkpoeKujaG1G6diRhiNCY9DnKA5zTMWZSJNTtGccEIjRmk6QxfetyQ8zotzNOP8QGTFHD2sPwE7awDbGntwY4cHW1ldmv1302MDOzAeh58DPToH_RYPDjZ92es9Ntb7S3RWl8bD1TEX6OP5ab18jVbvL2_Lx1WkOaXbSGlIFdVpzuoUFC9UIkqmWZWniRK1yMpK06TOC6EUS7MkJYLoWiWMEiaKMtd8gW6nuYOzXyP4rewar8GYsgc7eslCheWZyIqAJhOqXTjQQS0H13Sl20tK5MGdbOXkTh7cScJliFC7OW4YVQfVX-lXVgDuJyAogV0DTnrdQK-haoKdraxs8_-GH_70gZM</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Yorgancı, Ayçağ</creator><creator>Halici Ozturk, Filiz</creator><creator>Hancerliogullari, Necati</creator><creator>Çandar, Tuba</creator><creator>Caglar, Ali Turhan</creator><creator>Ozgu-Erdinc, A. Seval</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202105</creationdate><title>The role of serum podocalyxin levels in recurrent pregnancy loss</title><author>Yorgancı, Ayçağ ; Halici Ozturk, Filiz ; Hancerliogullari, Necati ; Çandar, Tuba ; Caglar, Ali Turhan ; Ozgu-Erdinc, A. Seval</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abortion, Habitual</topic><topic>Abortion, Induced</topic><topic>Case-Control Studies</topic><topic>Endothelial dysfunction</topic><topic>Female</topic><topic>Humans</topic><topic>Miscarriage</topic><topic>Podocalyxin</topic><topic>Pregnancy</topic><topic>Recurrent pregnancy loss</topic><topic>Sialoglycoproteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yorgancı, Ayçağ</creatorcontrib><creatorcontrib>Halici Ozturk, Filiz</creatorcontrib><creatorcontrib>Hancerliogullari, Necati</creatorcontrib><creatorcontrib>Çandar, Tuba</creatorcontrib><creatorcontrib>Caglar, Ali Turhan</creatorcontrib><creatorcontrib>Ozgu-Erdinc, A. Seval</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yorgancı, Ayçağ</au><au>Halici Ozturk, Filiz</au><au>Hancerliogullari, Necati</au><au>Çandar, Tuba</au><au>Caglar, Ali Turhan</au><au>Ozgu-Erdinc, A. Seval</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of serum podocalyxin levels in recurrent pregnancy loss</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>260</volume><spage>114</spage><epage>117</epage><pages>114-117</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><abstract>To measure serum levels of podocalyxin (PODXL) in recurrent miscarriages as a marker of vascular endothelial dysfunction.
In this case-control study, women who were hospitalized for singleton first-trimester pregnancy terminations due to missed abortion, anembryonic pregnancy, and inevitable abortion were included. There were 24 patients who were admitted for the first pregnancy termination, 39 patients who were admitted for recurrent pregnancy loss (RPL), and 25 fetal cardiac activity positive patients as the control group. Demographic features, medical and obstetric histories were recorded. The measurements of serum PODXL were done by a human enzyme-linked immunosorbent assay kit.
Serum PODXL levels were found to be significantly higher in the RPL group than the control group and the first time miscarriage group (13.82 [10.09−113.54] vs. 11.78 [9.25−48.80], p = 0.016 and 13.82 [10.09–113.54] vs. 11.99 [8.20–20.47], p = 0.003; respectively). Serum PODXL levels were not statistically significantly different between the first miscarriage and the control group (p = 0.62). There were positive correlation between serum PODXL levels and the number of gravida and the number of miscarriages (r = 0.217, p = 0.042, and r = 0.291, p = 0.006; respectively).
Recurrent miscarriage patients had higher serum levels of PODXL than both normal pregnancies and first-time miscarriages. Our results suggest that maternal endothelial dysfunction might have a role in recurrent pregnancy losses.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>33765479</pmid><doi>10.1016/j.ejogrb.2021.03.021</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-2115 |
ispartof | European journal of obstetrics & gynecology and reproductive biology, 2021-05, Vol.260, p.114-117 |
issn | 0301-2115 1872-7654 |
language | eng |
recordid | cdi_proquest_miscellaneous_2506287679 |
source | ScienceDirect Journals |
subjects | Abortion, Habitual Abortion, Induced Case-Control Studies Endothelial dysfunction Female Humans Miscarriage Podocalyxin Pregnancy Recurrent pregnancy loss Sialoglycoproteins |
title | The role of serum podocalyxin levels in recurrent pregnancy loss |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A48%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20serum%20podocalyxin%20levels%20in%20recurrent%20pregnancy%20loss&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Yorganc%C4%B1,%20Ay%C3%A7a%C4%9F&rft.date=2021-05&rft.volume=260&rft.spage=114&rft.epage=117&rft.pages=114-117&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2021.03.021&rft_dat=%3Cproquest_cross%3E2506287679%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c311t-bce5b1c582f5eb39b46a2c2d854b6f67adc14f896bb25745060cfb4210269a8c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2506287679&rft_id=info:pmid/33765479&rfr_iscdi=true |